Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

M Natsume, T Shimura, H Iwasaki, Y Okuda… - Cancer Chemotherapy …, 2019 - Springer
Purpose Ramucirumab (RAM) has been used as the second-line standard chemotherapy for
advanced gastric cancer (AGC) either alone or combination with paclitaxel (PTX). However,
no predictive biomarkers have been identified for RAM treatment in AGC. Methods We
retrospectively identified 26 patients who received either RAM monotherapy or RAM+ PTX
therapy for AGC refractory to fluoropyrimidine and platinum agents from 2015 to 2018 at
Nagoya City University Hospital. First, we extracted RNA using gastric cancer (GC) tissues …
被引用次数：14 相关文章 所有 5 个版本

[引用][C] Placental growth factor is a predictive biomarker for ramucirumab treatment in advanced gastric cancer

夏目まこと - 2020 - ci.nii.ac.jp
CiNii 博士論文 - Placental growth factor is a predictive biomarker for ramucirumab treatment
in advanced gastric cancer … Placental growth factor is a predictive biomarker for
ramucirumab treatment in advanced gastric cancer 胃癌に対するラムシルマブ療法の予測
因子の同定 … Placental growth factor is a predictive biomarker for ramucirumab treatment in
advanced gastric cancer …
相关文章 所有 4 个版本
以上显示的是最相近的搜索结果。 查看全部搜索结果